New European commissioners nominated

Published: 11-Sep-2014
Regulatory

Commission president Jean-Claude Juncker announces his planned team of commissioners for the next five years


The identity of the new EU trade commissioner charged with bringing the planned Trans-Atlantic Trade & Investment Partnership (TTIP) to conclusion has been unveiled. Cecilia Malmström, of Sweden, who is currently the EU’s home affairs commissioner, has been nominated to hold this sensitive position from 1 November.

The announcement came as incoming Commission president Jean-Claude Juncker announced his planned team of commissioners for the next five years. They also include a new health commissioner, Lithuania’s Vytenis Andriukaitis, a doctor and current health minister in his country. Another important nominee is the new internal market commissioner, Poland’s Elżbieta Bieńkowska, who is currently deputy prime minister in her country. Her new job would be powerful, given that she would also be responsible for EU industrial policy, including subsidies.

Another important appointment was Portugal’s Carlos Moedas, as research and innovation commissioner.

A novel aspect of the new Juncker Commission would be the appointment of influential vice presidents (also commissioners) given responsibility for broad areas of policy and the lower ranking commissioners involved in them. They would drive the key policy priority of the new Commission, which is economic growth and job creation. One of these vice presidents would be Estonia’s former prime minister Andrus Ansip, who would have responsibility for removing trade barriers within the EU and creating a more efficient European single market.

  • Companies:
  • European Commission
See more

You may also like

Regulatory

Timber Pharmaceuticals receives EC orphan drug designation

Read more
TMB-001 is a topical isotretinoin, formulated using the company’s patented IPEG delivery system

Trending Articles

  1. Overcoming CMC challenges in cell and gene therapy: part II Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC challenges inherent in producing cell and gene therapy (CGT) drugs
  2. Overcoming CMC challenges in cell and gene therapy: part I Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC challenges inherent in producing cell and gene therapy (CGT) drugs
  3. Momentum in the US cannabidiol market gains retailers' attention Walmart and other big-name stores in talks with food and drinks makers in preparation for the day CBD-enriched products are allowed on the shelves
  4. Ametek Mocon achieves accreditation for analytical testing laboratory Ametek Mocon, provider of instruments and services for testing, measuring and analysing a variety of gases, has achieved ISO/IEC 17025 accreditation for its Minneapolis analytical testing laboratory
  5. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for successful market entry from the early stages of development, reports Frederick Duynslaeger, Senior CMC Writer at Ardena

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

You may also like

Regulatory

Timber Pharmaceuticals receives EC orphan drug designation

TMB-001 is a topical isotretinoin, formulated using the company’s patented IPEG delivery system
Regulatory

European Commission purchases additional Moderna vaccine doses

Under the terms of the agreement, the European Commission has the option to purchase an additional 150 million doses to be delivered in 2022
Regulatory

Tagrisso receives full approval in the EU

For patients with locally-advanced or metastatic EGFR T790M mutation-positive non-small cell lung cancer
Regulatory

Medicine and food authorities strongly recommend re-think of antimicrobials use in livestock

EMA and EFSA give joint opinion on EU measures to reduce antimicrobials use in food-producing animals
Ingredients

Pharma industry says EDC criteria need a risk-based approach

Strict, science-based guidelines will be implemented as soon as possible
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

EU considers endocrine disrupter controls

It has long been known that pharmaceutical residues can become hormone-affecting ‘endocrine disrupters’ when released into the environment and future controls are likely – but how will the legislators tackle the issue? Manufacturing Chemist reports
Regulatory

European Commission, EMA and WHO step up co-operation to protect global public health

New working arrangement will allow timely sharing of non-public information
Subscribe now